Blood test to predict spread of digestive cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies a simple blood test that may help doctors predict if your digestive cancer (stomach, colon, or pancreatic) has spread to the lining of the belly. The goal is to better plan your treatment and avoid unnecessary surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with stomach, colon, or pancreatic cancer that is more than just a very early stage.
- Your cancer has not spread to other parts of the body (no metastases).
- You are eligible for surgery to remove the cancer.
- You have no other cancer in the past 5 years, and you are not under guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a blood-based test to detect unique molecules (called miRNAs) that may signal the presence of several types of gut or digestive system cancers. The goal is to develop a simple screening tool that could catch these cancers earlier.
This research study uses a blood test to look for signs of colorectal cancer in people who have other types of cancer or digestive diseases. The goal is to see if the test can correctly tell the difference between colorectal cancer and other conditions.
This study checks whether a blood liquid biopsy test can detect when stomach cancer has spread to the lining of the abdomen (peritoneal metastasis). It compares people with confirmed belly spread to people whose belly lining tests were negative, using blood samples before/around treatment decisions.
This study is testing whether a simple blood test can help find stomach cancer early, before symptoms appear. This could offer a less invasive way to detect the disease compared to a scope procedure.
This trial is looking for proteins in the blood that could help find stomach cancer earlier. If you have stomach cancer or are at risk, joining may help improve future diagnosis, and you'll have your blood drawn for testing.
This trial uses a blood test (ctDNA) to look for genetic material from tumors in patients with gastrointestinal cancers. It may help doctors understand and track your cancer better.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.